PTC THERAPEUTICS, INC. - 8-K Filing
PTC Therapeutics reports Q3 2026 total revenue of $358 million and raises full-year 2026 product revenue guidance to $960-$990 million. (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $PTCT